Literature DB >> 10333184

Prospective comparison of convergence insufficiency and normal binocular children on CIRS symptom surveys. Convergence Insufficiency and Reading Study (CIRS) group.

E Borsting1, M W Rouse, P N De Land.   

Abstract

PURPOSE: To test the validity-related evidence of a child and a parent symptom survey developed by the Convergence Insufficiency and Reading Study (CIRS) group.
METHODS: A case comparison method was used to measure differences in symptoms between 14 school-aged children (ages 8 to 13 years) with Convergence Insufficiency (CI) and 14 children with normal binocular vision (NBV).
RESULTS: A pooled t-test indicated that CI children and their parents scored higher than the NBV children and their parents on the child's survey (p<0.001) and parent's survey (p<0.001), respectively. CI children also scored significantly higher (p<0.03) on the Conners' Rating Scale for Parents.
CONCLUSIONS: The results suggest that the CIRS symptom survey is a valid instrument for differentiating CI children from those with normal binocular vision. Additionally, children in this age group were able to respond to a broad range of symptom questions associated with CI.

Entities:  

Mesh:

Year:  1999        PMID: 10333184     DOI: 10.1097/00006324-199904000-00025

Source DB:  PubMed          Journal:  Optom Vis Sci        ISSN: 1040-5488            Impact factor:   1.973


  34 in total

1.  Randomised clinical trial of the effectiveness of base-in prism reading glasses versus placebo reading glasses for symptomatic convergence insufficiency in children.

Authors:  M Scheiman; S Cotter; M Rouse; G L Mitchell; M Kulp; J Cooper; E Borsting
Journal:  Br J Ophthalmol       Date:  2005-10       Impact factor: 4.638

2.  2017 Glenn A. Fry Award Lecture: Establishing an Evidence-based Literature for Vision Therapy - A 25-year Journey.

Authors:  Mitchell M Scheiman
Journal:  Optom Vis Sci       Date:  2018-08       Impact factor: 1.973

3.  The Convergence Insufficiency Neuro-mechanism in Adult Population Study (CINAPS) Randomized Clinical Trial: Design, Methods, and Clinical Data.

Authors:  Tara L Alvarez; Mitchell Scheiman; Elio M Santos; Cristian Morales; Chang Yaramothu; John Vito D'Antonio-Bertagnolli; Bharat B Biswal; Suril Gohel; Xiaobo Li
Journal:  Ophthalmic Epidemiol       Date:  2019-10-22       Impact factor: 1.648

4.  Vision therapy/orthoptics for symptomatic convergence insufficiency in children: treatment kinetics.

Authors:  Mitchell Scheiman; Marjean Taylor Kulp; Susan Cotter; G Lynn Mitchell; Michael Gallaway; Mark Boas; Rachel Coulter; Kristine Hopkins; Susanna Tamkins
Journal:  Optom Vis Sci       Date:  2010-08       Impact factor: 1.973

5.  Long-term effectiveness of treatments for symptomatic convergence insufficiency in children.

Authors: 
Journal:  Optom Vis Sci       Date:  2009-09       Impact factor: 1.973

6.  Improvement in academic behaviors after successful treatment of convergence insufficiency.

Authors:  Eric Borsting; G Lynn Mitchell; Marjean Taylor Kulp; Mitchell Scheiman; Deborah M Amster; Susan Cotter; Rachael A Coulter; Gregory Fecho; Michael F Gallaway; David Granet; Richard Hertle; Jacqueline Rodena; Tomohiko Yamada
Journal:  Optom Vis Sci       Date:  2012-01       Impact factor: 1.973

7.  Randomized clinical trial of treatments for symptomatic convergence insufficiency in children.

Authors: 
Journal:  Arch Ophthalmol       Date:  2008-10

8.  Validity of the convergence insufficiency symptom survey: a confirmatory study.

Authors:  Michael Rouse; Eric Borsting; G Lynn Mitchell; Susan A Cotter; Marjean Kulp; Mitchell Scheiman; Carmen Barnhardt; Annette Bade; Tomohiko Yamada; Tomohike Yamada
Journal:  Optom Vis Sci       Date:  2009-04       Impact factor: 1.973

9.  Symptoms in children with convergence insufficiency: before and after treatment.

Authors:  Carmen Barnhardt; Susan A Cotter; G Lynn Mitchell; Mitchell Scheiman; Marjean T Kulp
Journal:  Optom Vis Sci       Date:  2012-10       Impact factor: 1.973

10.  Convergence Insufficiency Treatment Trial - Attention and Reading Trial (CITT-ART): Design and Methods.

Authors:  Mitchell Scheiman; G Lynn Mitchell; Susan A Cotter; Marjean Kulp; Christopher Chase; Eric Borsting; Eugene Arnold; Carolyn Denton; Richard Hertle
Journal:  Vis Dev Rehabil       Date:  2015-10
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.